More on Rosetta Stone's Q2: No explanation is given for the poor results. However, the company...

|About: Rosetta Stone Inc. (RST)|By:, SA News Editor

More on Rosetta Stone's Q2: No explanation is given for the poor results. However, the company notes international consumer sales fell 33% Y/Y to $8.1M, worse than Q1's 14% drop, and U.S. consumer swung from a 52% Q1 increase to a 4% decline. Institutional sales fell 2%, nearly even with Q1. Rosetta is expanding its 2012 adjusted EBITDA guidance range to the downside, but is leaving its revenue guidance unchanged. The Street appears skeptical. RST -23.8% AH. (PR)